首页> 外文期刊>Oncology letters >Systematic analysis of the molecular mechanism of microRNA-124 in hepatoblastoma cells
【24h】

Systematic analysis of the molecular mechanism of microRNA-124 in hepatoblastoma cells

机译:肝气肿细胞MicroRNA-124分子机制的系统分析

获取原文
获取原文并翻译 | 示例
           

摘要

The present study aimed to identify the molecular mechanisms of microRNA-124 (miRNA-124/miR-124) in hepatoblastoma. The GSE6207 microarray dataset, obtained from the Gene Expression Omnibus database, included samples extracted from HepG2 cells transfected with miR-124 duplex (the experimental group) or negative control (the control group) at 4, 8, 16, 24, 32, 72 and 120 h after transfection. Differentially expressed genes (DEGs) were screened between the two groups. miR-124 activity was inferred based on the expression of its target genes. The mRNAs targeted by miR-124 were predicted and a miR-124-target mRNA network was constructed. Gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes pathway enrichment analyses were performed for the target genes. The number of DEGs was highest at 72 h. The experimental group had higher miR-124 activity than that of the control group at 4, 8, 16, 24 and 120 h. Small GTPase-mediated signal transduction and Ras protein signal transduction were significant GO terms enriched with syndecan binding protein (SDCBP), Ras homolog family member G (RHOG) and Rho-GDP dissociation inhibitor-alpha (ARHGDIA). Regulation of actin cytoskeleton, D-glutamine and D-glutamate metabolism, and axon guidance were significant pathways. Axon guidance pathway was associated with neuropilin (NRP1), MET proto-oncogene, receptor tyrosine kinase (MET) and semaphorin 7A, GPI membrane anchor (SEMA7A). Small GTPase-mediated signal transduction, Ras protein signal transduction, regulation of actin cytoskeleton pathway, D-glutamine and D-glutamate metabolism pathway, axon guidance pathway, SDCBP, RHOG, ARHGDIA, NRP1, SEMA7A, and MET may be implicated in the underlying mechanisms of miR-124 overexpression in hepatoblastoma.
机译:本研究旨在鉴定肝脏母细胞瘤中MicroRNA-124(miRNA-124 / miR-124)的分子机制。从基因表达综合数据库获得的GSE6207微阵列数据集包括从用miR-124双链体(实验组)或阴性对照(对照组)在4,8,16,24,32,72转染的HepG2细胞中提取的样品转染后120小时。在两组之间筛选差异表达基因(DEGS)。基于其靶基因的表达推断出MiR-124活性。预测MiR-124靶向的MRNA,构建了miR-124-靶mRNA网络。对靶基因进行基因本体(GO)和基因组途径富集分析的基因本体(GO)和京都常规。 72小时的DEG数量最高。实验组具有比4,8,16,24和120h的对照组的更高miR-124活性。小GTP酶介导的信号转导和RAS蛋白信号转导是富含Syndecan结合蛋白(SDCBP),RAS同源物家庭成员G(rho-GDP解离抑制剂-α(Arhgdia)的显着的致新术语。调节肌动蛋白细胞骨架,D-谷氨酰胺和D-谷氨酸代谢和轴突引导是显着的途径。轴突引导途径与神经疏松素(NRP1)有关,MetOm-oncogene,受体酪氨酸激酶(MET)和信号蛋白7a,GPI膜锚(Sema7a)有关。小GTP酶介导的信号转导,RAS蛋白信号转导,actin细胞骨架途径,D-谷氨酰胺和D-谷氨酸代谢途径,轴突引导途径,SDCBP,rhog,arhgdia,NRP1,SEMA7a,并且可能涉及潜在的基础肝细胞瘤中miR-124过表达的机制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号